Home Opinion Page 199

Opinion

private equity, Chris Witkowsky
Welcome to our quarterly wrap-up issue, which could just as well be called “view from the peak.” What we saw in the second quarter — just like in the first quarter — is strong deal activity driven by aggressive general partners and hyper fundraising boosted by hungry limited partners. It’s all a function of the strong markets […]
private equity, mergers, M&A
First-time funds database gets an update, Accel-KKR secondary process buyers emerge
You signed an agreement to purchase a business, and still have a few months before closing. New regulations are announced which you expect will have a significant negative impact on the target’s business. You are starting to get cold feet—can you walk away before closing? In M&A transactions, one of the main risks that buyers […]
healthcare, private equity, medicine
Late night with Press Ganey: No Drama
Vesey Street seeks buyer for HealthChannels; Kolin, ex-Blackstone secondaries exec, joins Rothschild’s Five Arrows; the awkward conversation on key-person provisions
private equity, healthcare, IT, technology software, VSS
By Jeffrey Stevenson, VSS Digital-IT and population-health businesses enabling providers – doctors, community and hospital systems – to better analyze data from electronic health records, claims and clinical treatment are poised to become tomorrow’s healthcare-IT winners. This is happening as the industry’s transition from fee-for-service to value-based care has gained momentum. Value-based reimbursement models are […]
Key-person provisions lately are a hotly debated topic, with some GPs setting up several individuals, rather than one or two, as key people on a fund. This has the effect, at least from the LP perspective, of diluting the impact of a key-person provision. After all, a key-person provision that names one or two people […]
private equity, mergers, M&A
A GP fund restructuring comes full circle, Exploring the family office/independent sponsor ecosystem
healthcare, private equity, medicine
As Goldman writes big check in eye care, others steer clear of retail health
technology, software, SaaS. private equity, merger, m&a
By Scott Meyer, Glenview James LLC Everyone wants to invest in a high-growth software-as-a-service deal. It’s the holy grail. But many times PE investors spend hundreds of thousands of dollars on diligence, only to find out that the target business isn’t really SaaS after all. Here’s how to save time and money and make smarter […]
pehub
pehub

Copyright PEI Media

Not for publication, email or dissemination